Use of IR biotyper to improve classification of pathogens recovered from livestock and small animal patients - IR biotyper title: use of IR biotyper to improve classification of pathogens recovered…
Active Cooperative Agreement Awarded
- Award ID
- U18FD008929
- Recipient
-
University Of California, Davis UEI TX2DAGQPENZ5
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $100,000
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 18% complete
- Funding agency
- Food and Drug Administration Department of Health and Human Services
- Place of performance
- Davis, CA, USA
Award details come from USAspending.gov.
About this award
The U.S. Food and Drug Administration awarded Cooperative Agreement U18FD008929 to University of California, Davis on September 23, 2026, with $100,000 obligated under Food and Drug Administration Research (Assistance Listing 93.103). The award funds use of the IR Biotyper to improve classification of pathogens recovered from livestock and small animal patients, complementing MALDI-TOF for bacteria the recipient has already sequenced. Target organisms include bovine respiratory disease pathogens Mannheimia haemolytica and Pasteurella multocida; Campylobacter jejuni recovered from small ruminant abortions and food; Aeromonas spp. in aquaculture; and carbapenem-resistant Enterobacterales and Salmonella for infection control investigations at the university's teaching hospital. The recipient will also participate in exploring how the technology can be incorporated into clinical veterinary diagnostics, drawing on its expanding collection of fully sequenced clinical isolates. Performance runs through August 31, 2027, with place of performance in Davis, California.
Description
Use of IR biotyper to improve classification of pathogens recovered from livestock and small animal patients - IR biotyper title: use of IR biotyper to improve classification of pathogens recovered from livestock and small animal patients I have had several meetings with bruker scientists about the IR biotyper and had hoped IT would be in our laboratory's budget to purchase. But with recent state budget cuts, we won't be able to purchase IT. Uses I envision for the IR biotyper would be to compliment maldi-TOF in the classification of bacteria we have sequenced, including: bovine respiratory disease pathogens (mannheimia haemolytica and pasteurella multocida); campylobacter jejuni (recovered from small ruminant abortions and food); aquaculture aeromonas SPP.; as well as for investigations of infection control concerns in the teaching hospital (carbapenem resistant enterobacterales and salmonella). We would like to participate in the exploration of how this technology can be incorporated into clinical veterinary diagnostics and with our expanding collection of clinical isolates that have been fully sequenced, we believe we are in a good position to do this work
Quick answers
Who received award U18FD008929?
U18FD008929 was awarded to University Of California, Davis by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.
How much is award U18FD008929 worth?
$100,000 has been obligated on U18FD008929.
Which agency awarded U18FD008929?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008929, with funding from Food and Drug Administration (Department of Health and Human Services).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award